HAS2 and prostate carcinoma: HAS2, which encodes hyaluronan synthase 2, is overexpressed in multiple tumor types, including breast and prostate cancer [39, 40], and HAS2 reportedly promotes cancer cell invasion and metastasis [41, 42].